FDA Warns Against Unsupervised Use Of Malaria Drugs To Treat COVID-19
SILVER SPRING, Md. — The Food and Drug Administration on April 24 cautioned that hydroxychloroquine or chloroquine should not be used outside of a hospital setting or clinical trial due to...To view the full article, register now.
Already a subscriber? Click here to view full article